Yabao Pharmaceutical Group Co. Ltd.SSE: 600351

(600351)"Yabao Pharmaceutical Group Co., Ltd."Announcement on Progress of Capital Reduction of a Wholly-owned Subsidiary Following the Conversion of Capital Reserve into Registered Capital and Completion of Industrial and Commercial Registration Changes

· Issued by Yabao Pharmaceutical Group Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600351 ·

On 6ix: 6ix.com/news/600351yabao-pharmaceutical-group-co-ltdannouncement-on-progress-of-capital-reduction-of-a-wholly-owned-subsidiary-following-the-conversion-of-capital-reserve-into-registered-capital-and-completion-of-industrial-and-commercial-registration-changes

Announcement on Progress of Capital Reduction of a Wholly-owned Subsidiary Following the Conversion of Capital Reserve into Registered Capital and Completion of Industrial and Commercial Registration Changes

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

6ix is reading this filing.

View original source (Shanghai Stock Exchange)Yabao Pharmaceutical Group Co. Ltd. on 6ix

Story so far

Earlier from Yabao Pharmaceutical

All Yabao Pharmaceutical news releases